Jazz Pharmaceuticals (JAZZ) Current Deferred Tax Assets (2012 - 2015)

Jazz Pharmaceuticals' Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $50.0 million for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 40.09% year-over-year to $50.0 million; the TTM figure through Sep 2015 stood at $50.0 million (up 40.09% YoY), while the FY2014 annual figure was $48.4 million, up 44.11% from the prior year.
• Current Deferred Tax Assets was $50.0 million for Q3 2015 at Jazz Pharmaceuticals, down from $50.6 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $50.8 million in Q1 2015 to a low of $33.6 million in Q4 2013.
• Historically, Current Deferred Tax Assets has averaged $43.0 million across 4 years, with a median of $46.1 million in 2013.
• Biggest YoY gain for Current Deferred Tax Assets was 44.11% in 2014; the steepest drop was 24.47% in 2014.
• A 4-year view of Current Deferred Tax Assets shows it stood at $35.8 million in 2012, then dropped by 6.14% to $33.6 million in 2013, then soared by 44.11% to $48.4 million in 2014, then grew by 3.23% to $50.0 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $50.0 million (Q3 2015), $50.6 million (Q2 2015), and $50.8 million (Q1 2015), per Business Quant data.